Russell Investments Group’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,312
Closed -$288K 2746
2021
Q4
$288K Buy
10,312
+3,009
+41% +$98.7K ﹤0.01% 2623
2021
Q3
$304K Buy
7,303
+3,075
+73% +$129K ﹤0.01% 2646
2021
Q2
$195K Sell
4,228
-6,802
-62% -$337K ﹤0.01% 2914
2021
Q1
$607K Buy
11,030
+10,896
+8,131% +$722K ﹤0.01% 2448
2020
Q4
$9K Buy
+134
New +$15.7K ﹤0.01% 3007
2020
Q1
Sell
-1,562
Closed -$382K 3028
2019
Q4
$382K Sell
1,562
-3,312
-68% -$610K ﹤0.01% 2500
2019
Q3
$576K Buy
+4,874
New +$737K ﹤0.01% 2244

Other funds holding ASMB

Russell Investments Group's ASMB Position: Q1 2022 in Review

Russell Investments Group sold out of Assembly Biosciences (ASMB) in Q1 2022, closing a stake of 10,312 shares — an estimated $288K sold.

Russell Investments Group first reported a position in ASMB in Q3 2019 and held it in 7 quarters. The position peaked at $607K in Q1 2021. 54 funds tracked by Wall St. Rank hold ASMB as of Q1 2022.

  • Russell Investments Group reported no remaining Assembly Biosciences position as of Q1 2022 after selling out during the quarter.
  • Russell Investments Group sold 10,312 Assembly Biosciences shares in Q1 2022, an estimated $288K.
  • Russell Investments Group first reported a position in Assembly Biosciences in Q3 2019 and held it in 7 quarters.
  • Russell Investments Group's Assembly Biosciences position peaked at $607K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2022.

Based on Russell Investments Group's 13F filing for Q1 2022, filed 5 May 2022.